As technology plays a greater part in healthcare, more attention is being paid to how device surfaces and materials behave in terms of harboring micro-organisms, according to an article on the Business Solutions website.
The process of developing anti-microbial devices goes beyond using new materials to construct products. Contributing to the rise of antibiotic-resistant bacteria is also a concern, the article said.
"Antibiotics are developed and tested against microorganisms living in a planktonic or free-floating growth phase. When bacteria attach to surfaces, they begin to communicate, cooperate, and build a structured community … They become profoundly changed and different from that bacteria floating around in a broth, so the antibiotics that we order to kill them have limited effect,” Marcia Ryder of Ryder Science, a medical biofilm research facility, said in the article.
Optimizing the Engineering Design of Ambulatory Care Facilities
Construction Completed on Washington Health Urgent Care Facility in California
OhioHealth Pickerington Methodist Hospital Begins Expansion Project
IAQ and Infection Mitigation: Plans Into Actions
Case Study: How NYU Langone Rebuilt for Resilience After Superstorm Sandy